Back to top

Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3%
February 26, 2014

Read MoreHide Full Article

Oncothyreon Inc. was a big mover last session, as the company saw its shares jump a little over 9% on the day. This jump can be attributable to solid volume too with far more shares changing hands than in a normal session. This continues the most recent uptrend of the company, as the stock is now up 53% in the past one-month time frame.

Over the last 30 days, Oncothyreon did not witness any estimate revision and the Zacks Consensus Estimate has remained unchanged. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Oncothyreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN - Free Report) , Biogen Idec Inc. (BIIB - Free Report) with a Zacks Rank #1 (Strong Buy) and Cambrex Corporation.(CBM - Free Report) holding a Zacks Rank #2 (Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Alexion Pharmaceuticals, Inc. (ALXN) - free report >>

Biogen Inc. (BIIB) - free report >>

Cambrex Corporation (CBM) - free report >>


More from Zacks Tale of the Tape

You May Like